National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$21.00
add to cart

Rights & Permissions

topleft topright

Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals: Workshop Summary (2007)
Board on Health Sciences Policy (HSP)

Citation Manager

. "5 Drug-Drug Interactions." Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals: Workshop Summary. Washington, DC: The National Academies Press, 2007.

Please select a format:

BibTeX EndNote RefMan


Page
39
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals - Workshop Summary

information database (Lowe and Krulic, 2005). Hearst paid $19 million in settlement and divested Medi-Span (FTC, 2001).

Dr. Kahn proposed that a cross-disciplinary DDI working group be formed to create improved tools for communicating interactions and consequences. He believed that this group could identify and prioritize DDIs, develop a public database capable of receiving all new labeling information on drug interactions, perform an ongoing review of data from the FDA and the published literature, and possibly recommend specific interaction studies. He indicated that a model for the formation of such a group could be found in the National Coordinating Council for Medication Error Reporting and Prevention, an independent partnership of health-care organizations with the goal of reducing medical errors.

Page
39